ROSATOM plans to establish a subsidiary to market its technologies for nuclear medicine and irradiation and sterilization centres
16 January 2017 | World Nuclear News

ROSATOM plans to establish a subsidiary to market its technologies for nuclear medicine and irradiation and sterilization centres. According to a report by RIA Novosti, citing an unnamed source at the state nuclear corporation, the new company - Rusatom Healthcare - will have an authorised capital of RUB480 million ($8 million). It will be 100% owned by Atomenergoprom, the holding company that manages Russia's civilian nuclear assets.

Back

We use cookies to make our site as functional and convenient for the users as possible. By using our web site you agree that your personal data will be processed using the Google Analytics and Yandex Metrica web services.

.